HOME › DRUGS › APIXABAN
ACTIVE SUBSTANCE / INN

APIXABAN

Brand name(s): ELIQUIS SPRINKLE, ELIQUIS, Apixaban Accord, Eliquis, APIXABAN
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA210180
Arthroplasty;Venous Thromboembolism
ACTIVE SUBSTANCE
Apixaban
REGULATORS
FDA · EMA
SPONSORS / MAH
ACCORD HLTHCARE, BRISTOL, Bristol-Myers Squibb / Pfizer EEIG
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
APIXABANANDA209845BRECKENRIDGEDiscontinued
APIXABANANDA210180ACCORD HLTHCAREPrescription
APIXABANANDA209944SUNSHINE LAKENone (Tentative Approval)
ELIQUISNDA220073BRISTOLPrescription
ELIQUIS SPRINKLENDA220073BRISTOLPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EliquisBristol-Myers Squibb / Pfizer EEIGAuthorised18/05/2011Arthroplasty;Venous Thromboembolism
Apixaban AccordAccord Healthcare S.L.U.Authorised23/07/2020Venous Thromboembolism;Stroke;Arthroplasty

FULL INTELLIGENCE ON APIXABAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →